Matches in Wikidata for { <http://www.wikidata.org/entity/Q90753270> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q90753270 description "article scientifique publié en 2019" @default.
- Q90753270 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q90753270 description "scientific article published on 22 February 2019" @default.
- Q90753270 description "wetenschappelijk artikel" @default.
- Q90753270 description "наукова стаття, опублікована в лютому 2019" @default.
- Q90753270 name "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 name "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 type Item @default.
- Q90753270 label "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 label "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 prefLabel "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 prefLabel "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 P1433 Q90753270-EC72B51C-16DD-46AE-8065-1275D3C82FB6 @default.
- Q90753270 P1476 Q90753270-E7A403F0-D071-4896-AA03-BC8ABC10CD19 @default.
- Q90753270 P2093 Q90753270-3382DAFB-925C-475E-B7B9-42B7FB49A59E @default.
- Q90753270 P2093 Q90753270-4D48FF78-D10A-4298-BD9F-034D3AB52F00 @default.
- Q90753270 P2093 Q90753270-744F8004-9CB8-426A-8F3C-5116A07D4717 @default.
- Q90753270 P2093 Q90753270-80EF7FC4-8B65-4CF1-832A-F3010D7950B0 @default.
- Q90753270 P2093 Q90753270-AC5C460B-6192-4074-A7BD-6ECDE7788DA1 @default.
- Q90753270 P2093 Q90753270-D24104B8-9DFB-4191-995C-B6481886DE0E @default.
- Q90753270 P2093 Q90753270-E232F924-84BC-4C34-B37E-70143E63BF94 @default.
- Q90753270 P2093 Q90753270-EB00CD6F-BA20-4FCC-AFD3-07AEBDBF5FA3 @default.
- Q90753270 P2860 Q90753270-204F1FE3-0C86-4D18-9D7F-AC4B6BD77E28 @default.
- Q90753270 P2860 Q90753270-42DD1375-270B-483D-ADB2-A87D9FE933D1 @default.
- Q90753270 P2860 Q90753270-48EC737E-732C-4A1C-A380-34F2BB80A04D @default.
- Q90753270 P2860 Q90753270-4DE34542-F6D2-4091-ADED-9555767007D4 @default.
- Q90753270 P2860 Q90753270-5BD46120-EC5D-4B31-B5A9-081D1EC8C3A8 @default.
- Q90753270 P2860 Q90753270-6560D3DC-D5EF-4457-859A-2789A6797084 @default.
- Q90753270 P2860 Q90753270-6990C539-DB98-4EE5-AD5C-E6521E63081D @default.
- Q90753270 P2860 Q90753270-7BE6DE94-6177-40F7-AAB2-0C34696E445D @default.
- Q90753270 P2860 Q90753270-7EF1DCEF-80B7-4C7A-A69B-AA9F7B4D1C51 @default.
- Q90753270 P2860 Q90753270-98ECFAA9-72F0-406C-9588-68679B2AA30A @default.
- Q90753270 P2860 Q90753270-E5D9B2ED-3241-4BF8-8470-022A9C24A3F0 @default.
- Q90753270 P2860 Q90753270-F5E60AB0-1017-4FF6-8024-ABE13038A398 @default.
- Q90753270 P304 Q90753270-1C130F9D-18C0-4CC9-99B8-496A76EAEF75 @default.
- Q90753270 P31 Q90753270-88b358ba-2eaf-4801-9a6f-2932fb6934d1 @default.
- Q90753270 P31 Q90753270-F12F2127-C8BA-4AEA-9C62-CC6BDAC00B1D @default.
- Q90753270 P356 Q90753270-41CE6930-21B6-4535-9FE4-ADF0869C6F8E @default.
- Q90753270 P433 Q90753270-5005CBE6-73B7-4110-AA69-754D0C631DC5 @default.
- Q90753270 P478 Q90753270-FB08B8D8-A5CA-405C-8AE2-0881D12828A8 @default.
- Q90753270 P50 Q90753270-123BD109-742F-495B-B94C-096126AD8A6A @default.
- Q90753270 P577 Q90753270-B2459CCE-3FC4-439D-87DB-C427666CF45E @default.
- Q90753270 P698 Q90753270-9405A3D0-03B3-4BBD-BB50-7E5C477B62D6 @default.
- Q90753270 P921 Q90753270-CE2518B4-9E43-4F8A-AFD3-E2D0764C3E76 @default.
- Q90753270 P356 CPT.1338 @default.
- Q90753270 P698 30585620 @default.
- Q90753270 P1433 Q1101529 @default.
- Q90753270 P1476 "Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients" @default.
- Q90753270 P2093 "Alienor Berges" @default.
- Q90753270 P2093 "Helen Tomkinson" @default.
- Q90753270 P2093 "Hongmei Xu" @default.
- Q90753270 P2093 "Jianguo Li" @default.
- Q90753270 P2093 "Khanh Bui" @default.
- Q90753270 P2093 "Maria Learoyd" @default.
- Q90753270 P2093 "Nidal Al-Huniti" @default.
- Q90753270 P2093 "Tsveta Milenkova" @default.
- Q90753270 P2860 Q26778401 @default.
- Q90753270 P2860 Q28082178 @default.
- Q90753270 P2860 Q30499990 @default.
- Q90753270 P2860 Q33219671 @default.
- Q90753270 P2860 Q38637682 @default.
- Q90753270 P2860 Q38654552 @default.
- Q90753270 P2860 Q39933788 @default.
- Q90753270 P2860 Q43061803 @default.
- Q90753270 P2860 Q47155297 @default.
- Q90753270 P2860 Q54011326 @default.
- Q90753270 P2860 Q56807699 @default.
- Q90753270 P2860 Q57790872 @default.
- Q90753270 P304 "1492-1500" @default.
- Q90753270 P31 Q13442814 @default.
- Q90753270 P31 Q815382 @default.
- Q90753270 P356 "10.1002/CPT.1338" @default.
- Q90753270 P433 "6" @default.
- Q90753270 P478 "105" @default.
- Q90753270 P50 Q89401366 @default.
- Q90753270 P577 "2019-02-22T00:00:00Z" @default.
- Q90753270 P698 "30585620" @default.
- Q90753270 P921 Q7083106 @default.